Valproic Acid-Induced Lymphocytic Colitis in a Pediatric Patient: A Case report

Authors

  • Gustavo Javier Tagliaferro Médico gastroenterólogo pediatra. Hospital Italiano de Buenos Aires. Ciudad Autónoma de Buenos Aires, Argentina. https://orcid.org/0000-0002-9343-2819
  • María Soledad Arcucci Médico gastroenterólogo pediatra. Hospital Italiano de Buenos Aires. Ciudad Autónoma de Buenos Aires, Argentina.
  • Verónica Beatriz Busoni Médico gastroenterólogo pediatra. Hospital Italiano de Buenos Aires. Ciudad Autónoma de Buenos Aires, Argentina. https://orcid.org/0000-0003-3015-0598
  • Marina Orsi Médico gastroenterólogo pediatra. Hospital Italiano de Buenos Aires. Ciudad Autónoma de Buenos Aires, Argentina. https://orcid.org/0000-0001-6190-0254

DOI:

https://doi.org/10.52787/agl.v54i2.356

Keywords:

Microscopic colitis, lymphocytic colitis, chronic diarrhea, intraepithelial lymphocytes

Abstract

Microscopic colitis is an intestinal disease characterized by the development of chronic, watery, non-bloody diarrhea with normal appearing endoscopy. The entities that represent this group are collagenous colitis and lymphocytic colitis, which have characteristic histological features. Although microscopic colitis is considered a disease of low prevalence, studies presented in recent years show a slight increase in this pathology. It is often drug-induced and an autoimmune origin has been suggested as a trigger of inflammation. We describe the case of a pediatric patient who developed lymphocytic colitis during treatment with valproic acid, which resolved after withdrawal of the drug.

References

-1. Ohlsson B. New insights and challenges in microscopic colitis. Therap Adv Gastroenterol. 2015;8:37-47.

-2. Ortíz RGP, Ortíz JEP. Colitis microscópica, un diagnóstico en aumento. Revista Colombiana de Gastroenterología. 2019. pp.399-403. DOI:10.22516/25007440.377

-3. Guagnozzi D, Landolfi S, Vicario M. Towards a new paradigm of microscopic colitis: Incomplete and variant forms. World J Gastroenterol. 2016;22:8459-8471.

-4. Miehlke S, Verhaegh B, Tontini GE, Madisch A, Langner C, Münch A. Microscopic colitis: pathophysiology and clinical management. Lancet Gastroenterol Hepatol. 2019;4:305-314.

-5. Miehlke S, Guagnozzi D, Zabana Y, Tontini GE, Kanstrup Fiehn A-M, Wildt S, et al. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterol J. 2021. DOI: 10.1177/2050640620951905

-6. Singh P, Das P, Jain AK, Mathan M, Mathur M, Bhat AS, et al. microscopic colitis in children with chronic diarrhea. J Pediatr Gastroenterol Nutr. 2013;57:240-244.

-7. Kuhn BR, Mezoff AG. Pediatric lymphocytic colitis presenting with intractable diarrhea. J Pediatr Gastroenterol Nutr. 2011;53:579-581.

-8. Lucendo AJ. Drug Exposure and the Risk of Microscopic Colitis: A Critical Update. Drugs in R&D. 2017. pp. 79-89. DOI:10.1007/s40268-016-0171-7

-9. Beaugerie L, Luboinski J, Brousse N, Cosnes J, Chatelet FP, Gendre JP, et al. Drug induced lymphocytic colitis. Gut. 1994;35:426-428.

-10. Narla NP, Smyrk TC, Pardi DS, Tung J. Clinical features, and treatment responses in pediatric lymphocytic and collagenous colitis. J Pediatr Gastroenterol Nutr. 2013;57:557-561.

-11. Álvarez-Pérez P, Rubio-Nazábal E, Marey-López J, López-Facal S, del Corral PR. Colitis linfocitaria inducida por carbamacepina. Anales de Medicina Interna. 2004. DOI:10.4321/s0212-71992004001100019

-12. Yantiss RK, Odze RD. Optimal approach to obtaining mucosal biopsies for assessment of inflammatory disorders of the gastrointestinal tract. Am J Gastroenterol 2009;104:774-783.

-13. Langner C, Aust D, Ensari A, Villanacci V, Becheanu G, Miehlke S, et al. Histology of microscopic colitis-review with a practical approach for pathologists. Histopathology. 2015;66:613-626.

-14. González IA, Conrad M, Weinbrom S, Patel T, Kelsen JR, Russo P. Clinicopathologic Characterization of Lymphocytic Colitis in the Pediatric Population. Pediatr Dev Pathol. 2023;10935266231215117

-15. Stewart MJ, Seow CH, Storr MA. Prednisolone and budesonide for short- and long-term treatment of microscopic colitis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2011;9:881-890.

-16. Miehlke S, Aust D, Mihaly E, Armerding P, Böhm G, Bonderup O, et al. Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis. Gastroenterology. 2018;155:1795-1804.e3.

-17. Enwerem NY, Yen EF. The colitis may be microscopic, but the diarrhea is not: update on the treatment of microscopic colitis and immune checkpoint inhibitor colitis. Curr Opin Gastroenterol. 2024;40 50-59.

Published

2024-07-01

How to Cite

Tagliaferro, G. J., Arcucci, M. S., Busoni, V. B., & Orsi, M. (2024). Valproic Acid-Induced Lymphocytic Colitis in a Pediatric Patient: A Case report. Acta Gastroenterológica Latinoamericana, 54(2), 202–207. https://doi.org/10.52787/agl.v54i2.356